Fulgent Genetics (FLGT) Liabilities from Discontinued Operations (2015)
Fulgent Genetics' (FLGT) quarterly Liabilities from Discontinued Operations came in at $173000.0 in Q4 2015.
Analysis
Fulgent Genetics (FLGT) Liabilities from Discontinued Operations (2015) Analysis & Trends
Fulgent Genetics has disclosed Liabilities from Discontinued Operations across 1 years of filings, most recently posting $173000.0 for Q4 2015.
- In Q4 2015, Liabilities from Discontinued Operations changed N/A year-over-year to $173000.0; the TTM figure through Dec 2015 stood at $173000.0 (changed N/A YoY), while the FY2015 annual figure was $173000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations came in at $173000.0 for Q4 2015 at Fulgent Genetics.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of $173000.0 in Q4 2015 to a low of $173000.0 in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn |
| 10 | Fulgent Genetics | 596.80 Mn | 334.14 Mn | 25.68 Mn |